Indication
Stevens-Johnson syndrome
Stevens-Johnson syndrome is an acute, life-threatening type IV mucocutaneous hypersensitivity reaction characterized by extensive keratinocyte apoptosis, leading to epidermal detachment and mucosal sloughing. Read more about Stevens-Johnson syndrome
48 drugs 35 manufacturers
Drugs that treat it
Common Stevens-Johnson syndrome therapies.
PREDNISOLONE SODIUM PHOSPHATE
PREDNISOLONE SODIUM PHOS ODT (prednisolone sodium phosphate)
ACTHAR (corticotropin)
CORTROPHIN GEL (corticotropin)
MILLIPRED (prednisolone)
PREDNISOLONE
PREDNISOLONE SODIUM PHOSPHATE
PREDNISOLONE SODIUM PHOSPHATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonStevens-Johnson syndrome is an acute, life-threatening type IV mucocutaneous hypersensitivity reaction characterized by extensive keratinocyte apoptosis, leading to epidermal detachment and mucosal sloughing.
Representing the less extensive presentation along a shared disease spectrum with toxic epidermal necrolysis, it specifically features epidermal necrosis and detachment involving less than 10% of the total body surface area.
The condition predominantly affects adults—particularly individuals with specific human leukocyte antigen variants or underlying immunodeficiency—and typically presents with a systemic flu-like prodrome followed by painful coalescing macules, bullae, and painful erosions involving at least two mucosal sites, most commonly the oral cavity, ocular conjunctiva, and genitalia.
- nih.gov
Stevens-Johnson syndrome is an acute, life-threatening type IV mucocutaneous hypersensitivity reaction characterized by extensive keratinocyte apoptosis, leading to epidermal detachment and mucosal sloughing Representing the less extensive presentation along a shared disease spectrum with toxic epidermal necrolysis, it specifically features epidermal necrosis and detachment involving less than 10% of the total body surface area The condition predominantly affects adults—particularly individuals ...
- nih.gov
Stevens-Johnson syndrome is an acute, life-threatening type IV mucocutaneous hypersensitivity reaction characterized by extensive keratinocyte apoptosis, leading to epidermal detachment and mucosal sloughing The condition predominantly affects adults—particularly individuals with specific human leukocyte antigen variants or underlying immunodeficiency—and typically presents with a systemic flu-like prodrome followed by painful coalescing macules, bullae, and painful erosions involving at least t...
- nih.gov
Stevens-Johnson syndrome is an acute, life-threatening type IV mucocutaneous hypersensitivity reaction characterized by extensive keratinocyte apoptosis, leading to epidermal detachment and mucosal sloughing Representing the less extensive presentation along a shared disease spectrum with toxic epidermal necrolysis, it specifically features epidermal necrosis and detachment involving less than 10% of the total body surface area The condition predominantly affects adults—particularly individuals ...
- medlineplus.gov
The condition predominantly affects adults—particularly individuals with specific human leukocyte antigen variants or underlying immunodeficiency—and typically presents with a systemic flu-like prodrome followed by painful coalescing macules, bullae, and painful erosions involving at least two mucosal sites, most commonly the oral cavity, ocular conjunctiva, and genitalia
Personalize your experience
Follow Stevens-Johnson syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.